Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/10889
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChin, Ruthen
dc.contributor.authorNachbur, Ulrichen
dc.contributor.authorEarnest-Silveira, Lindaen
dc.contributor.authorBankovacki, Aleksandraen
dc.contributor.authorKoeberlein, Bernden
dc.contributor.authorZentgraf, Hanswalteren
dc.contributor.authorBock, C-Thomasen
dc.contributor.authorSilke, Johnen
dc.contributor.authorTorresi, Josephen
dc.date.accessioned2015-05-16T00:27:59Z
dc.date.available2015-05-16T00:27:59Z
dc.date.issued2009-09-26en
dc.identifier.citationVirus Research 2009; 147(1): 7-16en
dc.identifier.govdoc19786052en
dc.identifier.otherPUBMEDen
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/10889en
dc.description.abstractDysregulation of the cell cycle is frequently associated with tumor development. Hepatitis B virus (HBV) is associated with a significant risk of developing hepatocellular carcinoma but the effects of HBV on cell cycle regulation are not completely understood.We have used a recombinant adeno-HBV model system to investigate the effect of infection with HBV and the replication defective lamivudine resistant mutant rtM204I mutant on hepatocyte cell cycle and cell viability.Huh7 cells synchronised at the G1/S phase of the cell cycle were arrested at the G2/M following infection with rAdHBV-wt and rAdHBV-M204I. This was accompanied by increased levels of p21(cip1), p-cdc2, cyclins D, A and B. Cell viability was reduced and cleaved caspase 3 levels were increased in HBV- and rtM204I-infected cells. rAdHBV-M204I-infected Huh7 cells also demonstrated significant up-regulation of phospho-ERK, phospho-Akt, p53 and phospho-Mdm2 compared to mock-infected cells. These changes were comparable to those following infection of Huh7 cells with rAdHBV-wt.Our results suggest that HBV, regardless of phenotype, produces cell cycle arrest and reduced hepatocyte viability. Perturbations in these cellular processes are likely to underlie HBV-associated liver oncogenic transformation and may help explain the ongoing risk of developing hepatocellular carcinoma in individuals in whom the lamivudine resistant rtM204I mutant emerges.en
dc.language.isoenen
dc.subject.otherCell Cycleen
dc.subject.otherCell Cycle Proteins.analysisen
dc.subject.otherCell Lineen
dc.subject.otherCell Survivalen
dc.subject.otherHepatitis B virus.pathogenicityen
dc.subject.otherHepatocytes.chemistry.physiology.virologyen
dc.subject.otherHumansen
dc.subject.otherProtein Kinases.analysisen
dc.subject.otherSignal Transductionen
dc.titleDysregulation of hepatocyte cell cycle and cell viability by hepatitis B virus.en
dc.typeJournal Articleen
dc.identifier.journaltitleVirus researchen
dc.identifier.affiliationrchin@unimelb.edu.auen
dc.identifier.affiliationDepartment of Medicine, Austin Hospital, University of Melbourne, Heidelberg, Victoria 3084, Australiaen
dc.identifier.doi10.1016/j.virusres.2009.09.012en
dc.description.pages7-16en
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/19786052en
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.